Immunomodulatory ellagitannin chemistry

Chemistry and Biology of Ellagitannins: An Underestimated Class of Bioactive Plant Polyphenols

Volumn , Issue , 2009, Pages 203-272

  Coca, Adiel ^a   Feldman, Ken S ^a   Lawlor, Michael D ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELLAGITANNIN; IMMUNOMODULATORY;

EID: 78649396893     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812797414_0006     Document Type: Chapter

References (218)

1. Aggarwal, B., Kohr, W., Hass, P., Moffat, B., Spencer, S., Henzel, W., Bringmans, T., Nedwins, G., Goeddels, D. and Harkins, R. (1985). Human tumor necrosis factor. production, purification, and characterization, J. Biol. Chem., 260, pp. 2345-2354.
2. Akagawa, K. S. and Tokunaga, T. (1985). Lack of binding of bacterial lipopolysaccharide to mouse lung macrophages and restoration of binding by gamma interferon, J. Exp. Med., 162, pp. 1444-1459.
3. Akira, S. and Takeda, K. (2004). Toll-like receptor signaling, Nat. Rev. Immunol., 4, pp. 499-511.
4. Amakura, Y., Tsutsumi, T., Sasaki, K., Yoshida, T. and Maitani, T. (2003). Screening of the inhibitory effect of vegetable constituents on the aryl hydrocarbon receptor-mediated activity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Biol. Pham. Bull., 26, pp. 1754-1760.
5. Amersfoort, E., Van Berkel, T. and Kuiper, J. (2003). Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock, Clin. Microbiol. Rev., 16, pp. 379-414.
6. Aoki, K., Nishimura, K., Abe, H., Maruta, H., Sakagami, H., Hatano, T., Okuda, T., Yoshida, T., Tsai, Y., Uchiumi, F. and Tanuma, S. (1993). Novel inhibitors of poly(ADP-ribose) glycohydrolase, Biochimica et Biophysica Acta, 1158, pp. 251-256.
7. Arditi, M., Zhou, J., Dorio, R., Rong, G., Goyert, S. and Kim, K. (1993). Endotoxinmediated endothelial cell injury and activation: role of soluble CD14, Infect. Immun., 61, pp. 3149-3156.
8. Balza, E., Mortara, L., Sassi, F., Monteghirfo, S., Carnemolla, B., Castellani, P., Neri, D., Accolla, R., Zardi, L. and Borsi, L. (2006). Targeted delivery of tumor necrosis factor-a to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin, Clin. Can. Res., 12, pp. 2575-2582.
9. Barbehenn, R., Jones, C., Hagerman, A., Karonen, M. and Salminen, J. (2006a). Ellagitannins have greater oxidative activities than condensed tannins and galloyl glucoses at high pH: potential impact on caterpillars, J. Chem. Ecol., 32, pp. 2253-2267.
10. Barbehenn, R., Jones, C., Karonen, M. and Salminen, J. (2006b). Tannin composition affects the oxidative activities of tree leaves, J. Chem. Ecol., 32, pp. 2235-2251.
11. Bereta, J., Cohen, M. and Bereta, M. (1995). Stimulatory effect of ouabain on VCAM-1 and iNOS expression in murine endothelial cells: involvement of NF-kB, FEBS Letters, 377, pp. 21-25.
12. Beutler, A., Milsark, I. and Cerami, A. (1985). Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effect of endotoxin, Science, 229, pp. 869-871.
13. Bhakdi, S., Klonisch, T., Nuber, P. and Fischer, W. (1991). Stimulation of monokine production by lipoteichoic acids, Infect. Immun., 59, pp. 4614-4620.
14. Black, R., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J. and Cerretti, D. P. (1997a). A metalloproteinase disintegrin that releases tumour-necrosis factor-a from cells, Nature, 385, pp. 729-733.
15. Black, R., Bird, T. and Mohler, K. (1997b). Agents that block TNF-a synthesis or activity, Ann. Rep. Med. Chem, 32, pp. 241-250.
16. Blick, M., Sherwin, S. A., Roseblum, M. and Gutterman, J. (1987). Phase I study of recombinant tumor necrosis factor in cancer patients, Cancer Res., 47, pp. 2986-2989.
17. Bone, R. C. (1991). The pathogenesis of sepsis, Ann. Intern. Med., 115, pp. 457-469.
18. Byrd-Leifer, C., Block, E., Takeda, K., Akira, S. and Ding, A. (2001). The role of MyD88 and TLR4 in the LPS-mimetic activity of taxol, Eur. J. Immunol., 31, pp. 2448-2457.
19. Carswell, E. A., Old, L. J., Kassel, R. L, Green, S., Fiore, N. and Williamson, B. (1975). An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Natl. Acad. Sci., 72, pp. 3666-3670.
20. Cavaillon, J.-M. (2003). Proinlammatory and Anti-inflammatory Cytokines as Mediators of Gram-Negative Sepsis. In Cytokines and Chemokines in Infectious Diseases Handbook, ed. by Kotb, M. and Calandra, T., Humana Press, Inc.: Totowa, NJ, pp. 33-57.
21. Chan, M. (1995). Inhibition of tumor necrosis factor by curcumin, a phytochemical, Biochem. Pharmacol., 49, pp. 1551-1556.
22. Chang, C.-M. and Nowotny, A. (1975). Relation of structure to function in bacterial O-antigens. VII. Endotoxicity of lipid A, Immunochemistry, 12, pp. 19-28.
23. Chen, L., Yen, K., Yang, L., Hatano, T., Okuda, T. and Yoshida, T. (1999). Macrocyclic ellagitannins dimers, cuphiins D1 and D2, and accompanying tannins from Cuphea hyssopifolia, Phytochemistry, 50, pp. 307-312.
24. Cherney, R., King, B., Gilmore, J., Liu, R., Covington, M., Duan, J. and Decicco, C. (2006). Conversion of potent MMP inhibitors into selective TACE inhibitors, Bioorg. Med. Chem. Lett., 16, pp. 1028-1031.
25. Chilman-Blair, K., Leeson, P. and Bayes, M. (2003). Treatment of septic shock TLR4 (LPS) receptor antagonist, Drugs of the Future, 28, pp. 633-639.
26. Coley, W. B. (1896). The therapeutic value of the mixed toxins of the streptococcus of Erysipelas and Bacillus prodigious in the treatment of inoperable malignant tumors, Am. J. Med. Sci., 112, pp. 251-281.
27. Colotta, F., Ghezzi, P. and Mantovani, A. (1998). Interleukin 1. In Cytokines, ed. by Mire-Sluis, A. and Thorpe, R., Academic Press: San Diego, CA, pp. 1-18.
28. Corti, A. and Ponzoni, M. (2004). Tumor vascular targeting with tumor necrosis factor a and chemotherapeutic drugs, Ann. NY Acad. Sci., 1028, pp. 104-112.
29. Curnis, F., Sachi, A. and Corti, A. (2002). Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration, J. Clin. Invest., 110, pp. 475-482.
30. Darveau, R., Pham, T., Lemley, K., Reife, R., Bainbridge, B., Coats, S., Howald, W., Way, S. and Hajjar, A. (2004). Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4, Infect. Immun., 72, pp. 5041-5051.
31. Dauphinee, S. and Karsan, A. (2006). Lipopolysaccharide signaling in endothelial cells, Laboratory Investigation, 86, pp. 9-22.
32. Davey, P. and Ashrafian, H. (2000). New therapies for heart failure: is thalidomide the answer? QJM, 93, pp. 305-311.
33. Demchenko, A. V., Wolfert, M. A., Santhanam, B., Moore, J. N. and Boons, G.-J. (2003). Synthesis of biological evaluation of Rhizobium sin-1 lipid A derivatives, J. Am. Chem. Soc., 125, pp. 6103-6112.
34. Dheen, S., Jun, Y., Yan, Z., Tay, S. and Ling, E. (2005). Retinoic acid inhibits expression of TNF-a and iNOS in activated rat microglia, Glia, 50, pp. 21-31.
35. Dinarello, C., Cannon, J., Wolff, S., Bernheim, H., Beutler, B., Cerami, A., Figari, I., Palladino, M. and O’Connor, J. (1986). Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1, J. Exp. Med., 163, pp. 1433-1450.
36. Dinarello, C. (1989). Interleukin-1 and its biologically related cytokines. In Advances in Immunology, vol. 44, ed. by Dixon, F., Academic Press: San Diego, CA, pp. 153-205.
37. Ding, A., Porteu, F., Sanchez, E. and Nathan, C. (1990). Shared actions of endotoxin and taxol TNF receptors and TNF release, Science, 248, pp. 370-372.
38. Dixon, D. R. and Darveau, R. P. (2005). Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid A structure, J. Dent. Res., 84, pp. 584-595.
39. Dunzendorfer, S., Lee, H., Soldau, K. and Tobias, P. (2004). TLR4 is the signaling but not the lipopolysaccharide uptake receptor, J. Immunol., 173, pp. 1166-1170.
40. Durum, S., Schmidt, J. and Oppenheim, J. (1985). Interleukin 1: an immunological perspective, Annu. Rev. Immunol., 3, pp. 263-287.
41. Evans, T., Strivens, E., Carpenter, A. and Cohen, J. (1993). Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous Gram-negative infection, J. Immunol., 150, pp. 5033-5040.
42. Feldman, K., Sahasrabudhe, K., Smith, R. and Scheuchenzuber, W. (1999) Immuno stimulation by plant polyphenols: a relationship between tumor necrosis factor-a production and tannin structure, Bioorg. & Med. Chem. Lett., 9, pp. 985-990.
43. Feldman, K., Wilson, S., Lawlor, M., Lang, C. and Scheuchenzuber, W. (2002). In vitro and in vivo inhibition of LPS-induced tumor necrosis factor-a production by dimeric gallotannin analogues, Bioorg. Med. Chem., 10, pp. 47-55.
44. Feldman, K. and Lawlor, M. (2000). Ellagitannin chemistry: the first total synthesis a dimeric ellagitannin, coriariin A, J. Am. Chem. Soc., 122, pp. 7396-7397.
45. Feldman, K., Lawlor, M. and Sahasrabudhe, K. (2000). Ellagitannin Chemistry. Evolution of a three-component coupling strategy for the synthesis of the dimeric ellagitannin coriariin A and a dimeric gallotannin analogue, J.Org. Chem., 65, pp. 8011-8019.
46. Feng, W., Zheng, X., Yoshida, T. and Okuda, T. (1996). Five hydrolyzable tannins from Potentilla discolor Bunge, Tianran Chanwu Yanjiu Yu Kaifa, 8, pp. 26-30.
47. Fey, G. H., Hocke, G., Wilson, D., Ripperger, J., Juan, T., Cui, M. and Darlington, G. (1994). Cytokines and the acute phase response of the liver. In The liver: Biology andPathobiology, ed. by Arias, I., Boyer, J., Fausto, N., Jakoby, W., Schachter, D. and Shafritz, D., Raven Press: New York, pp. 113-143.
48. Fischer, E., Marano, M., Barber, A., Hudson, A., Lee, K., Rock, C.S., Hawes, A. S., Thompson, R. C., Hayes, T. J. and Anderson, T. D. (1991). Comparison between effects of interleukin-1 alpha administration and sublethal endotoxemia in primates, Am. J. Physiol. Regul. Integr. Comp. Physiol., 261, pp. R442-R452.
49. Flad, H., Loppnow, H., Rietschel, E. and Ulmer, A. (1993). Agonists and antagonists for lipopolysaccharide-induced cytokines, Immunobiol., 187, pp. 303-316.
50. Folli, S., Pelegrin, A., Chalandon, Y., Yao, X., Buchegger, F., Lienard, D., Lejeune, F. and Mach, J. (1993). Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability, Int. J. Cancer, 53, pp. 829-836.
51. Fong, Y., Tracey, K., Moldawer, L., Hesse, D., Manogue, K., Kenney, J., Lee, A., Kuo, G., Allison, A., Lowry S. and Cerami, A. (1989). Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia, J. Exp. Med., 170, pp. 1627-1633.
52. Frendeus, B., Wachtler, C., Hedlund, M., Fischer, H., Samuelsson, P., Svensson, M. and Svanborg, C. (2001). Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation, Mol. Microbiol., 40, pp. 37-51.
53. Friedman, G., Silva, E. and Vincent, J. L. (1998). Has the mortality of septic shock changed with time? Crit. Care Med., 26, pp. 2078-2086.
54. Fukuchi, K., Sakagami, H., Okuda, T., Hatano, T., Tanuma, S., Kitajima, K., Inoue, Y., Inoue, S., Ichikawa, S., Nonoyama, M. and Konno, K. (1989). Inhibition of Herpes simplex virus infection by tannins and related compounds, Antiviral Res., 11, pp. 285-298.
55. Gazzano-Santoro, H.; Meszaros, K., Birr, C., Carroll, S., Theofan, G., Horwitz, A., Lim, E., Aberle, S., Kasler, H. and Parent, J. (1994). Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and Gram-negative bacteria, Infect. Immun., 62, pp. 1185-1191.
56. Gery, I. and Waksman, B. (1972). Potentiation of the T-lymphocyte response to mitogens: II. The cellular source of potentiating mediator(s), J. Exp. Med., 136, pp. 143-155.
57. Goyert, S., Ferrero E., Rettig, W., Yenamandra, A., Obata, F., and Le Beau, M. (1988). The CD 14 monocyte differentiation antigen maps to a region encoding growth factors and receptors, Science, 239, pp. 497-500.
58. Hampton, R., Golenbock, D., Penman, M., Krieger, M. and Raetz, C. (1991). Recognition and plasma clearance of endotoxin by scavenger receptors. Nature, 352, pp. 342-344.
59. Hashimoto, T., Suganuma, M., Fujiki, H., Yamada, M., Kohno, T. and Asakawa, X. (2003). Isolation and synthesis of TNF-a release inhibitors from Fijian kawa (Piper methysticum), Phytomedicine, 10, pp. 309-317.
60. Hatano, T., Hattori, S. and Okuda, T. (1986). Tannins of Coriaria japonica A. Gray. I. Coriariins A and B, new dimeric and monomeric hydrolyzable tannins, Chem. Pharm. Bull., 34, pp. 4092-4097.
61. Hatano, T., Yasuhara, T., Matsuda, M., Yazaki, K., Yoshida, T. and Okuda, T. (1989). Oenothein B, a dimeric hydrolyzable tannin of cyclic structure, Chem. Pharm. Bull., 37, pp. 2269-2271.
62. Hatano, T., Yasuhara, T., Matsuda, M., Yazaki, K., Yoshuda, T. and Okuda, T. (1990). Oenothein B, a dimeric, hydrolyzable tannin with macrocyclic structure, and accompanying tannins from Oenothera erythrosepala, J. Chem. Soc., Perkin Trans. 1, pp. 2735-2743.
63. Havell, E., Fiers, W. and North, R. (1988). The antitumor function of tumor necrosis factor (TNF), J. Exp. Med., 167, pp. 1067-1085.
64. Hayashi, F., Smith, K., Ozinsky, A., Hawn, T., Yi, E., Goodlett, D., Eng, J., Akira, S., Underhill, D. and Aderem, A. (2001). The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5, Nature, 410, pp. 1099-1103.
65. Haziot, A., Ferrero, E., Kontgen, F., Hijiya, N., Yamamoto, S., Silve, J., Stewart, C. and Goyert, S. (1996). Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice, Immunity, 4, pp. 407-414.
66. Haziot, A., Hijiya, N., Schultz, K., Zhang, F., Gangloff, S. and Goyert, S. (1999). CD14 plays no major role in shock induced by Staphylococcus aureus but down-regulates TNF-a production, J. Immunol., 162, pp. 4801-4805.
67. 2and Chlamydophyla psittacy 6BC, Eur. J. Biochem., 270, pp. 440-450.
68. Heinzel, F. P., Rerko, R., Ling, P., Hakimi, J. and Schoenhaut, D. (1994). Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon, Infect. Immun., 62, pp. 4244-4249.
69. Helson, L., Green, S., Carswell, E. and Old, L. J. (1975). Effect of tumour necrosis factor on cultured human melanoma cells, Nature, 258, pp. 731-732.
70. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K. and Akira, S. (2000). A Toll-like receptor recognizes bacterial DNA, Nature, 408, pp. 740-745.
71. Herath, H., Takano-Ishikawa, Y. and Yamaki, K. (2003). Inhibitory effect of some flavonoids on tumor necrosis factor-a production in lipopolysaccharide-stimulated mouse macrophage cell line J774.1, J. Med. Food, 6, pp. 365-370.
72. Herman, J., Dinarello, C., Kew, M. and Rabson, A. (1985). The role of interleukin 1 (IL 1) in tumor-NK cell interactions: correction of defective NK cell activity in cancer patients by treating target cells with IL 1, J. Immunol., 135, pp. 2882-2886.
73. Hoshino, K., Takeuchi, O, Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. and Akira, S. (1999). Cutting Edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product, J. Immunol., 162, pp. 3749-3752.
74. Hrenn, A., Steinbrecher, T., Labahn, A., Schwager, J., Schempp, C. and Merfort, I. (2006). Plant phenolics inhibit neutrophil elastase, Planta Med, 72, pp. 1127-1131.
75. Hukkanen, A., Kokko, H., Buchala, A., McDougall, G., Stewart, D., Karenlampi, S. and Karjalainen, R. (2007). Benzothiadiazole induces the accumulation of phenolics and improves resistance to powdery mildew in strawberries, J. Agric. Food Chem., 55, pp. 1862-1870.
76. Ingalls, R. R. and Golenbock, D. (1995). CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide, J. Exp. Med., 181, pp. 1473-1479.
77. Iontcheva, I., Amar, S., Zawawi, K., Kantarci, A. and Van Dyke, T. (2004). Role for moesin in lipopolysaccharide-stimulated signal transduction, Infect. Immun., 72, pp. 2312-2320.
78. Ito, H., Nishitani, E., Hatano, T., Nakanishi, T., Inada, A., Murata, H., Inatomi, Y., Matsuura, N., Ono, K., Lang, F., Murata, J. and Yoshida, T. (2001). Tannins and related polyphenols, HIV reverse transcriptase inhibitors, from Rosa woodsii, Nat. Med, 55, p. 218.
79. Jaeschke, H. (1996). Chemokines, neutrophils, and inflammatory liver injury, Shock, 6, pp. 403-404.
80. Jang, S., Jeong, S., Kim, K., Kim, H., Yu, H., Park, R., Kim, H. and You, Y. (2003). Tanshinone IIA from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-a, IL-1ß and IL-6 in activated RAW 264.7 cells, Planta Med, 69, pp. 1057-1059.
81. Jeong, H., Koo, H., Na, H., Kim, M., Hong, S., Eom, J., Kim, K., Shin, T. and Kim, H. (2002). Inhibition of TNF-a and IL-6 production by aucubin through blockade of NF-kB activation in RBL-2H3 mast cells, Cytokine, 18, pp. 252-259.
82. Jones, E., Staurt, D. and Walker, N. (1992). Crystal structure of TNF, Immunol. Ser., 56, pp. 93-127.
83. Ju, H., Baek, S., An, R., Bae, K., Son, K., Kim, H., Kang, S., Lee, S., Son, J. and Chang, H. (2003). Inhibitory effects of nardostachin on nitric oxide, prostaglandin E2, and tumor necrosis factor-a production in lipopolysaccharide activated macrophages, Biol. Pharm. Bull., 26, pp. 1375-1378.
84. Kanoh, R., Hatano, T., Ito, H., Yoshida, T. and Akagi, M. (2000). Effects of tannins and related polyphenols on superoxide-induced histamine release from rat peritoneal mast cells, Phytomedicine, 7, pp. 297-302.
85. Kawai, T., Takeuchi, O., Fujita, T., Inoue, J., Muhlradt, P., Sato, S., Hoshino, K. and Akira, S. (2001). Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes, J. Immunol., 167, pp. 5887-5894.
86. Keller, R., Fischer, W., Keist, R. and Bassetti, S. (1992). Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids, Infect. Immun., 60, pp. 3664-3672.
87. Kemeny N., Childs, B., Larchian, W., Rosado, K. and Kelsen, D. (1990). A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma, Cancer, 66, pp. 659-663.
88. Kengatharan, M., De Kimpe, S. and Thiemermann, C. (1996). Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages, Br. J. Pharmacol, 117, pp. 1163-1170.
89. Kim, E., Jin, H., Kim, Y., Lee, H., Lee, S., Lee, K., Zee, O., Han, J. and Lee, H. (2001). Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-kappaB activation, Biochem. Pharmacol, 61, pp. 903-910.
90. 2from LPS-stimulated cell line, RAW 264.7 cells, Fitoterapia, 75, pp. 261-266.
91. Kiss, A., Kowalski, J. and Melzig, M. (2004). Compounds from Epilobium angustifolium inhibit the specific metallopeptidases ACE, NEP and APN, Planta Med, 70, pp. 919-923.
92. Kolodziej, H., Kayser, O., Kiderlen, A., Ito, H., Hatano, T., Yoshida, T. and Foo, L. (2001). Antileishmanial activity of hydrolyzable tannins and their modulatory effects on nitric oxide and tumour necrosis factor-a release in macrophages in vitro, Planta Med, 67, pp. 825-832.
93. Koshiura, K., Miyamoto, K., Ikeya, Y. and Taguchi, H. (1985). Antitumor activity of methanol extract from roots of Agrimonia pilosa Ledeb, Jpn. J. Pharmacol., 38, pp. 9-16.
94. Kristensen, C., Nozue, M., Boucher, Y. and Jain, R. (1996). Reduction of interstitial fluid pressure after TNF-a treatment of three human melanoma xenografts, Br. J. Cancer, 74, pp. 533-536.
95. Kubo, I., Yokokawa, Y. and Kinst-Hori, I. (1995). Tyrosinase inhibitors from bolivian medicinal plants, J. Nat. Prod., 58, pp. 739-743.
96. Kuipers, B., van der Poll, T., Levi, M., van Deventer, S., Ten Cate, H., Imai, Y., Hack, E. and Ten Cate, J. (1994). Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees, J. Immunol., 152, pp. 2438-2446.
97. Lee, M., Chiou, J., Yen, K. and Yang, L. (2000). EBV DNA polymerase inhibition of tannins from Eugenia uniflora, Cancer Letters, 154, pp. 131-136.
98. Lee, S., Lee, H., Ji, S., Lee, S., Mar, W. and Gho, Y. (2004). 1,2,3,4,6-Penta-O-galloyl-ß-D-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor, Cancer Letters, 208, pp. 89-94.
99. Lehmann, V. and Rupprecht, E. (1977). Microheterogeneity in lipid A demonstrated by a new intermediate in the biosynthesis of 3-deozy-D-manno-octulosonic-acid-lipid A. Eur. J. Biochem., 81, pp. 443-452.
100. Lesuisse, D., Berjonneau, J., Ciot, C., Devaux, P., Doucet, B., Gourvest, J., Khemis, B., Lang, C., Legrand, R., Lowinski, M., Maquin, P., Parent, A., Schoot, B. and Teutsch, G. (1996). Determination of oenothein B as the active 5-a-reductase-inhibiting principle of the folk medicine Epilobium parviflorum, J. Nat. Prod., 59, pp. 490-492.
101. Lien, E., Chow, J., Hawkins, L., McGuinness, P., Miyake, K., Espevik, T., Gusovsky, F. and Golenbock, D. (2001). A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/Toll-like receptor 4 signaling pathway, J. Biol. Chem., 276, pp. 1873-1880.
102. Lin, J. and Wang, J. (1998). Hydrolyzable tannins possessing a dehydrodigalloyl group from the fruit of Rosa taiwanensis Nakai., Chin. Pharm. J., 50, pp. 167-173.
103. Liu, W. C., Oikawa, M., Fukase, K., Suda, Y., Winarno, H., Mori, S., Hashimoto, M. and Kusumoto, S. (1997). Enzymatic preparation of (S)-3-hydroxytetradecanoic acid and synthesis of unnatural analogues of lipid A containing the (S)-acid, Bull. Chem. Soc. Jpn., 70, pp. 1441-1450.
104. Liu, Y., Zhang, W., Cheung, L., Niu, T., Wu, Q., Li, C., Van Pelt, C. and Rosenblum, M. (2006). The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts, Neoplasia, 8, pp. 384-393.
105. Loppnow, H., Stelter, F., Schonbeck, U., Schluter, C., Ernst, M., Schutt, C. and Flad, H. (1995). Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14, Infect. Immun., 63, pp. 1020-1026.
106. Lund, K. and Rimpler, H. (1985). Tormentilla root. Isolation of an ellagitannin and pharmacological screening, Deutsche Apot. Zeit., 125, pp. 105-108.
107. Malhotra, R., Priest, R. and Bird, M. (1996). Role for L-selectin in lipopolysaccharide-induced activation of neutrophils, Biochem. J., 320, pp. 589-593.
108. Malhotra, R. and Bird, M. (1997). L-selectin - a signaling receptor for lipopolysaccharide, Chemistry & Biology, 4, pp. 543-547.
109. Malhotra, R., Priest, R., Foster, M. and Bird, M. (1998). P-selectin binds to bacterial lipopolysaccharide, Eur. J. Immunol., 28, pp. 983-988.
110. Manjula, N., Gayathri, B., Vinaykumar, K., Shankernarayanan, N., Vishwakarma, R. and Balakrishnan, A. (2006). Inhibition of MAP kinases by crude extract and pure compound isolated from Commiphora mukul leads to down regulation of TNF-a, IL-1 ß and IL-2, Int. Immunopharmacol., 6, pp. 122-132.
111. Martin, G. S., Mannino, D. M., Eaton, S. and Moss, M. (2003). The epidemiology of sepsis in the United States from 1979 through 2000, N. Engl. J. Med., 348, pp. 1546-1554.
112. nin the maintenance of DNA replication apparatus during DNA repair, Biol. Pharm. Bull., 30, pp. 447-450.
113. Matsumori, A., Shioi, T., Yamada, T., Matsui, S. and Sasayama, S. (1994). Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure, Circulation, 89, pp. 955-958.
114. Matsumori, A., Ono, K., Nishio, R., Igata, H., Shioi, T., Matsui, S., Furukawa, Y., Iwasaki, A., Nose, Y. and Sasayama, S. (1997). Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain, Circulation, 96, pp. 1501-1506.
115. Maury, C. and Teppo, A. (1987). Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection, J. Exp. Med., 166, pp. 1132-1137.
116. McMahan, C., Slack, J. and Mosley, B. (1991). A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types, EMBO J., 10, pp. 2821-2832.
117. Meredith, T. C., Aggarwal, P., Mamat, U., Lindner, B. and Woodward, R. W. (2006). Redefining the requisite lipopolysaccharide structure in Escherichia coli, ACS Chem. Biol., 1, pp. 33-42.
118. Miyamoto, K., Koshiura, R., Ikeya, Y. and Taguchi, H. (1985). Isolation of agrimoniin, an antitumor constituent, from the roots of Agrimonia pilosa Ledeb, Chem. Pharm. Bull., 33, pp. 3977-3981.
119. Miyamoto, K., Kishi, N. and Koshiura, R. (1987a). Antitumor effect of agrimoniin, a tannin of Agrimonia pilosa Ledeb., on transplantable rodent tumors, Jpn. J. Pharmacol, 43, pp. 187-195.
120. Miyamoto, K., Kishi, N., Koshiura, R., Yoshida, T., Hatano, T. and Okuda, T. (1987b). Relationship between the structures and the antitumor activities of tannins, Chem. Pharm. Bull., 35, pp. 814-822.
121. Miyamoto, K., Kishi, N., Murayama, T., Furukawa, T. and Koshiura, R. (1988). Induction of cytotoxicity of peritoneal exudate cells by agrimoniin, a novel immunomodulatory tannin of Agrimoniin pilosa Ledeb. Cancer Immunol. Immunother., 27, pp. 59-62.
122. Miyamoto, K., Murayama, T., Nomura, M., Hatano, T., Yoshida, T., Furukawa, T., Koshiura, R. and Okuda, T. (1993a). Antitumor activity and Interleukin-1 induction by tannins, Anticancer Res., 13, pp. 37-42.
123. Miyamoto, K., Nomura, M., Murayama, T., Furukawa, T., Hatano, T., Yoshida, T., Koshiura, R. and Okuda, T. (1993b). Antitumor activities of ellagitannins against sarcoma-180 in mice, Biol. Pharm. Bull, 16, pp. 379-387.
124. Miyamoto, K., Nomura, M., Sasakura, M., Matsui, E., Koshiura, R., Murayama, T., Furukawa, T., Hatano, T., Yoshida, T. and Okuda, T. (1993c). Antitumor activity of oenothein B, a unique macrocyclic Ellagitannin, Jpn. J. Cancer Res., 84, pp. 99103.
125. Miyamoto, K., Murayama, T., Hatano, T., Yoshida, T. and Okuda, T. (1999). Host-mediated anticancer activities of tannins. In Plant Polyphenols 2: Chemistry, Biology, Pharmacology, and Ecology, ed. by Gross, G., Hemingway, R. W., Yoshida, T., Kluwer Academic/Plenum Publishers: New York, pp. 643-663.
126. Moreira, A., Sampaio, E., Zmuidzinas, A., Frindt, P., Smith, K. and Kaplan, G. (1993). Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation, J. Exp. Med., 177, pp. 1675-1680.
127. Muller, G., Chen, R., Huang, S., Corral, L., Wong, L., Patterson, R., Chen, Y., Kaplan, G. and Stirling, D. (1999). Amino-substituted thalidomide analogs: potent inhibitors of TNF-a production, Bioorg. Med. Chem. Lett., 9, pp. 1625-1630.
128. Murakami, A., Nishizawa, T., Egawa, K., Kawada, T., Nishikawa, Y., Uenakai, K. and Ohigashi, H. (2005). New class of linoleic acid metabolites biosynthesized by corn and rice lipoxygenases: Suppression of proinflammatory mediator expression via attenuation of MAPK- and Akt-, but not PPARy-, dependent pathways in stimulated macrophages, Biochem. Pharmacol., 70, pp. 1330-1342.
129. Murayama, T., Kishi, N., Koshiura, R., Takagi, K., Furukawa, T. and Miyamoto, K. (1992). Agrimoniin, an antitumor tannin of Agrimonia pilosa Ledeb., induces interleukin-1, Anticancer Res., 12, pp. 1471-1474.
130. Murray, J., Rosenblum, M., Lamki, L., Haynie, T., Glenn, H., Plager, C., Unger, M., Carlo, D. and Hersh, E. (1987). Radio immunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen, NCI Monogr., 3, pp. 3-9.
131. Muto, Y., Nouri-Aria, K. and Meager, A. (1988). Enhanced tumour necrosis factor and interleukin-1 in fulmiminant hepatic failure, Lancet, 332, pp. 72-74.
132. Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., Kimoto, M. and Miyake, K. (2002). Essential role of MD-2 in LPS responsiveness and TLR4 distribution, Nat. Immunol., 3, pp. 667-672.
133. Newton, R. and Decicco, C. (1999). Therapeutic potential and strategies for inhibiting tumor necrosis factor-a, J. Med. Chem., 42, pp. 2295-2314.
134. Nikaido, H. and Vaara, M. (1985). Molecular basis of bacterial outer membrane permeability, Microbiol. Rev., 49, pp. 1-32.
135. Nutini, L., Prince, J., Duarte, A., Juhasz, R. and Cook, S. (1963). Influence of tumor fractions on incidence of spontaneous mammary tumors in C3H/HeJ mice, Proc. Soc. Exp. Biol. Med., 112, pp. 315-318.
136. Okuda, T., Mori, K., Shiota, M. and Ida, K. (1982a). Effect of the interaction of tannins with coexisting substances. II. Reduction of heavy metal ions and solubilization of precipitates, Yakugaku Zasshi, 102, pp. 735-742.
137. Okuda, T., Mori, K. and Shiota, M. (1982b). Effects of the interaction of tannins with coexisting substances. III. Formation and solubilization of precipitates with alkaloids, Yakugaku Zasshi, 102, pp. 854-858.
138. Okuda, T., Yoshida, T., Kuwahara, M., Memon, M. and Shingu, T. (1982c). Agrimoniin and potentillin, an ellagitannin dimer and monomer having an a-glucose core, J. Chem. Soc., Chem. Commun., pp. 163-164.
139. Okuda, T., Yoshida, T., Kuwahara, M., Memon, M. and Shingu, T. (1984). Tannins of rosaceous medicinal plants. I. Structures of potentillin, agrimonic acids A and B, and agrimoniin, a dimeric ellagitannin, Chem. Pharm. Bull., 32, pp. 2165-2173.
140. Okuda, T., Yoshida, T. and Hatano, T. (1993). Classification of oligomeric hydrolysable tannins and specificity of their occurrence in plants, Phytochemistry, 32, pp. 507-521.
141. Okusawa, S., Gelfand, J., Ikejima, T., Connally, R. and Dinarello, C. (1988). Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition, J. Clin. Invest., 81, pp. 1162-1172.
142. Park, S., Han, S., Lee, K., Lee, H., Kho, Y., Chun, H., Choi, Y., Yang, J., Yoon, Y., Lee, C., Kim, H., Choi, H., Tae, H., Lee, H., Nam, K. and Han, G. (2006). Gelastatins and their hydroxamates as dual functional inhibitors for TNF-a converting enzyme and matrix metalloproteinases: synthesis, biological evaluation, and mechanism studies, Biochem. Biophys. Res. Comm., 341, pp. 627-634.
143. Parrillo, J. (1993). Pathogenic mechanisms of septic shock. N. Eng. J. Med., 328, pp. 1471-1477.
144. Pahan, K., Sheikh, F., Namboodiri, A. and Singh, I. (1997). Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages, J. Clin. Invest., 100, pp. 2671-2679.
145. Paul, A., Gohil, V. and Bhutani, K. (2006). Modulating TNF-a signaling with natural products, Drug Discovery Today, 11, pp. 725-732.
146. Perera, P. Y., Mayadas, T., Takeuchi, O., Akira, S., Zaks-Zilberman, M., Goyert, S. and Vogel, S. (2001). CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression, J. Immunol., 166, pp. 574-581.
147. Pittet, D., Tarara, D. and Wenzel, R. P. (1994). Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality, JAMA, J. Am. Med. Assoc., 271, pp. 1598-1601.
148. Posadas, I., Terencio, M., Randazzo, A., Gomez-Paloma, L., Paya, M. and Alcaraz, M. (2003). Inhibition of the NF-kB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M, Biochem. Pharmacol., 65, pp. 887-895.
149. Priestle, J., Schar, H. and Grutter, M. (1988). Crystal structure of the cytokine interleukin-1ß, EMBO J, 7, pp. 339-343.
150. Priestle, J., Schar, H. and Grutter, M. (1989). Crystallographic refinement of interleukin 1ß at 2.0 angstrom resolution, Proc. Natl. Acad. Sci. USA, 86, pp. 9667-9671.
151. Qureshi, N., Takayama, K. and Kurtz, R. (1991). Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice, Infect. Immun., 59, pp. 441-444.
152. Raetz, C. (1990). Biochemistry of endotoxins, Ann. Rev. Biochem., 59, pp. 129-170.
153. Ramadori, G., Meyer zum Buschenfelde, K., Tobias, P., Mathison, J. and Ulevitch, R. (1990). Biosynthesis of lipopoly saccharide-binding protein in rabbit hepatocytes, Pathobiology, 58, pp. 89-94.
154. Reitschel, E. T., Brade, H., Holst, O., Brade, L., Muller-Loennies, S., Mamat, U., Zahringer, U., Beckmann, F., Seydel, U., Brandenburg, K., Ulmer, A. J., Mattern, T., Heine, H., Schletter, J., Loppnow, H., Schonbeck, U., Flad, H.-D., Hauschildt, S., Schade, U. F., Di Padova, F., Kusumoto, S. and Schumann, R. R. (1996). Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. In Pathology of Septic Shock, ed. by Reitschel, E. T. and Wagner, H., Springer: New York, pp 39-81.
155. Rietschel, E. T. and Westphal, O. (1999). Endotoxin: historical perspectives. In Endotoxin in Health and Disease, ed. by Brade, H., Opal, S., Vogel, S. N. and Morrison, D. C., Marcel Dekker, Inc.: New York, pp. 1-30.
156. Rinehart, J., Balcerzak, S. and Hersh, M., (1990). Phase II trial of tumor necrosis factor in human sarcoma, Proc. Am. Soc. Clin. Oncol., 9, pp. 317 (abstr 1229).
157. Roberts, F. J., Geere, I. W. and Coldman, A (1991). A three-year study of positive blood cultures, with emphasis on prognosis, Rev. Infect. Dis., 13, pp. 34-46.
158. Rosenblum, M., Cheung, L., Murray, J. and Bartholomew, R. (1991). Antibody-mediated delivery of tumor necrosis factor (TNF-a): improvement of cytotoxicity and reduction of cellular resistance, Cancer Commun., 3, pp. 21-27.
159. Rossignol, D. and Lynn, M. (2005). TLR4 antagonists for endotoxemia and beyond, Curr. Opin. Inv. Drugs, 6, pp. 496-502.
160. Rudolphi, K., Gerwin, N., Verzijl, N., van der Kraan, P., and van den Berg, W. (2003). Pralnacasan, an inhibitor of interleukin-1ß converting enzyme, reduces joint damage in two murine models of osteoarthritis, Osteoart. Cartilage, 11, pp. 738-746.
161. Ruegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P. and Lejeune, F. (1998). Evidence for the involvement of endothelial cell integrin aVß3 in the disruption of the tumor vasculature induced by TNF and IFN-y, Nat. Med., 4, pp. 408-414.
162. Ryu, J., Son, H., Lee, S. and Sohn, D. (2002). Two neolignans from Perilla frutescens and their inhibition of nitric oxide synthase and tumor necrosis factor-a expression in murine macrophage cell line Raw 264.7, Bioorg. Med. Chem. Lett., 12, pp. 649-651.
163. Sacchi, A., Gasparri, A., Gallo-Stampino, C., Toma, S., Curnis, F. and Corti, A. (2006). Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-a, Clin. Cancer. Res., 12, pp. 175-182.
164. Sakagami, H., Asano, K., Tanuma, S., Hatano, T., Yoshida, T. and Okuda, T. (1992). Stimulation of monocyte iodination and IL-1 production by tannins and related compounds, Anticancer Res., 12, pp. 377-387.
165. Sakagami, H., Jiang, Y., Kusama, K., Atsumi, T., Ueha, T., Toguchi, M., Iwakura, I., Satoh, K., Ito, H., Hatano, T. and Yoshida, T. (2000). Cytotoxic activity of hydrolyzable tannins against human oral tumor cell lines - A possible mechanism, Phytochemistry, 7, pp. 39-47.
166. Sampaio, E., Sarno, E., Galilly, R., Cohn, Z. and Kaplan, G. (1991). Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes, J. Exp. Med., 173, pp. 699-703.
167. Schumann, R., Leong, S., Flaggs, G., Gray, P., Wright, S., Mathison, J., Tobias, P. and Ulevitch, R. (1990). Structure and function of lipopolysaccharide binding protein, Science, 249, pp. 1429-1431.
168. Schumann, R. and Zweigner, J. (1999). A novel acute-phase marker. Lipopolysaccharide binding protein (LBP), Clin. Chem. Lab. Med., 37, pp. 271-274.
169. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., and Kirschning, C. (1999). Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Tolllike receptor 2, J. Biol. Chem., 274, pp. 17406-17409.
170. Senzer, N., Mani, S., Rosemurgy, A., Nemunaitis, J., Cunningham, C., Guha, C., Bayol, N., Gillen, M., Chu, K., Rasmussen, C., Rasmussen, H., Kufe, C., Weichselbaum, R. and Hanna, N. (2004). TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors, J. Clin. Oncol., 22, pp. 592-601.
171. Seternes, T., Dalmo, R., Hoffman, J., Begwald, J., Zykova, S. and Smedsrad, B. (2001). Scavenger-receptor-mediated endocytosis of lipopolysaccharide in Atlantic cod (Gadus morhua L.), J. Exp. Biol., 204, pp. 4055-4064.
172. Sharma, V. K. and Dellinger, R. P. (2003). Recent developments in the treatment of sepsis. Expert Opin. Investig. Drugs, 12, pp. 139-152.
173. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K. and Kimoto, M. (1999). MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4, J. Exp. Med, 189, pp. 1777-1782.
174. Shiozaki, M., Doi, H., Tanaka, D., Shimozato, T. and Kurakata, S. (2006). Syntheses of glucose analogues of E5564 as a highly potent anti-sepsis drug candidate, Bioorg. Med. Chem, 14, pp. 3011-3016.
175. Shnyra, A., Lindberg, A. (1995). Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro, Infect. Immun., 63, pp. 865-873.
176. Sidhu, R. and Bollon, A. (1993). Tumor necrosis factor activities and cancer therapy - a perspective, Pharmacol. Ther., 57, pp. 79-128.
177. Smith, C., Farrah, T. and Goodwin, R. (1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death, Cell, 76, pp. 959-962.
178. Solomon, K., Kurt-Jones, E., Saladino, R., Stack, A., Dunn, I., Ferretti, M., Golenbock, D., Fleisher, G. and Finberg, R. (1998). Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide, J. Clin. Invest., 102, pp. 2019-2027.
179. Spriggs, D. and Yates, S. (1992). Cancer chemotherapy, experiences with TNF-administration in humans. In Tumor Necrosis Factor: The Molecules and Their Emerging Roles in Medicine, ed. by Beutler, B., Raven Press: New York, pp. 383-406.
180. Steel, D. and Whitehead, A. (1994). The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein, Immunol. Today, 15, pp. 81-88.
181. Szlosarek, P., Charles, K. and Balkwill, F. (2006). Tumour necrosis factor-a as a tumour promoter, Eur. J Cancer, 42, pp. 745-750.
182. Takeda, K. and Akira, S. (2004). TLR signaling pathways, Sem. Immunol., 16, pp. 3-9.
183. Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K. and Akira, S. (1999). Differential roles of TLR2 and TLR4 in recognition of Gramnegative and Gram-positive bacterial cell wall components, Immunity, 11, pp. 443-451.
184. Takeuchi, O., Hoshino, K. and Akira, S. (2000). Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection, J. Immunol, 165, pp. 5392-5396.
185. Taveira da Silva, A. M., Kaulbach, H. C., Chuidian, F. S., Lambert, D. R., Suffredini, A. F. and Danner, R. L. (1993). Brief report: shock and multiple-organ dysfunction after self-administration of salmonella endotoxin, N. Engl. J. Med., 328, pp. 1457-1460.
186. Thom, A., Alexander, H. and Andrich, M. (1995). Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan, J. Clin. Oncol. 13, pp. 264-273.
187. Tobias, P., Soldau, K. and Ulevitch, R. (1989). Identification of a lipid A binding site in the acute phase-reactant lipopolysaccharide binding protein, J. Biol. Chem., 264, pp. 10867-10871.
188. Tohme, Z., Amar, S. and Van Dike, T. (1999). Moesin functions as a lipopolysaccharide receptor on human monocytes, Infect. Immun., 67, pp. 3215-3220.
189. Tracey, K., Fong, Y., Hesse, D., Manogue, K., Lee, A., Kuo, G., Lowry, S. and Cerami, A. (1987). Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia, Nature, 330, pp. 662-664.
190. Triantafilou, M., Triantafilou, K. and Dedrick, R. (2001). A CD 14-independent LPS receptor cluster, Nat. Immunol., 2, pp. 338-346.
191. Triantafilou, M. and Triantafilou, K. (2002) Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster, Trends Immunol, 23, pp. 301-304.
192. Tse, A., Wan, C., Shen, X., Yang, M. and Fong, W. (2005). Honokiel inhibits TNF-a stimulated NF-kB activation and NF-KB-regulated gene expression through suppression of IKK activation, Biochem. Pharmacol., 70, pp. 1443-1457.
193. Verbon, A., Dekkers, P., ten Hove, T., Hack, C., Pribble, J., Turner, T., Souza, S., Axtelle, T., Hoek, F., van Deventer, S. and van der Poll, T. (2001). IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans, J. Immunol., 166, pp. 3599-3605.
194. Vishnyakova, T., Bocharov, A., Baranova, I., Chen, Z., Remaley, A., Csako, G., Eggerman, T., Patterson, A. (2003). Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1, J. Biol. Chem, 278, pp. 22771-22780.
195. Wagner, D., Combes, A., McTiernan, C., Sanders, V., Lemster, B. and Feldman, A. (1998). Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-a, Circ. Res., 82, pp. 47-56.
196. Wang, J., Jorgensen, P., Almlof, M., Thiemermann, C., Foster, S., Aasen, A. and Solberg, R. (2000). Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model, Infect. Immun., 68, pp. 3965-3970.
197. Wheeler, A. P. and Bernard, G. R. (1999). Treating patients with severe sepsis, N. Engl. J. Med., 340, pp. 207-214.
198. Wright, S. D. and Jong, M. (1986). Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide, J. Exp. Med, 164, pp. 1876-1888.
199. Wright, S. D., Tobias, P., Ulevitch, R. and Ramos, R. (1989). Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages, J. Exp. Med, 170, pp. 1231-1241.
200. Wright, S. D., Ramos, R., Tobias, P., Ulevitch, R. and Mathison, J. (1990a). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science, 249, pp. 1431-1433.
201. Wright, S. D., Detmers, P., Aida, Y., Adamowski, R., Anderson, D., Chad, Z., Kabbash, L. and Pabst, M. (1990b). CD18-deficient cells respond to lipopolysaccharide in vitro, J. Immunol, 144, pp. 2566-2571.
202. Wright, S. (1995). CD14 and innate recognition of bacteria, J. Immunol., 155, pp. 6-8.
203. Xagorari, A., Papapetropoulos, A., Mauromatis, A., Economou, M., Fotsis, T. and Roussos, C. (2001). Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages, J. Pharmacol. Exp. Ther., 296, pp. 181-187.
204. Yan, L., Anderson, G., DeWitte, M. and Nakada, M. (2006). Therapeutic potential of cytokine and chemokine antagonists in cancer therapy, Eur. J Cancer, 42, pp. 793-802.
205. Yin, N., Marshall, R. L., Matheson, S. and Savage, P. B. (2003). Synthesis of lipid A derivatives and their interactions with polymyxin B and polymyxin B nonapeptide, J. Am. Chem. Soc., 125, pp. 2426-2435.
206. Yong, K. L. and Linch, D. (1993). Granulocyte-macrophage-colony-stimulating factor differentially regulates neutrophil migration across IL-1-activated and nonactivated human endothelium, J. Immunol., 150, pp. 2449-2456.
207. Yoshida, T., Tanaka, K., Chen, X.-M. and Okuda, T. (1989a). Tannins of rosaceous medicinal plants. Part 7. Dimeric ellagitannins, laevigatins E, F, and G, from Rosa laevigata, Phytochemistry, 28, pp. 2451-2454.
208. Yoshida, T., Tanaka, K., Chen, X.-M. and Okuda, T. (1989b). Tannins of Rosaceous medicinal plants. V. Hydrolyzable tannins with dehydrodigalloyl group from Rosa laevigata Michx., Chem. Pharm. Bull., 37, pp. 920-924.
209. Yoshida, T., Jin, Z. and Okuda, T. (1989c). Tannins of rosaceous medicinal plants. Part 6. Taxifolin apioside and davuriciin Mi, a hydrolysable tannin from Rosa davurica, Phytochemistry, 28, pp. 2177-2181.
210. Yoshida, T., Chou, T., Nitta, A. and Okuda, T. (1989d). Woodfordins A, B and C, dimeric hydrolyzable tannins from Woodfordia fruticosa flowers, Heterocycles, 29, pp. 2267-2271.
211. Yoshida, T., Chou, T., Nitta, A., Miyamoto, K., Koshiura, R. and Okuda, T. (1990). Woodfordin C, a macro-ring hydrolyzable tannin dimer with antitumor activity, and accompanying dimers from Woodfordia fruticosa flowers, Chem. Pharm. Bull, 38, pp. 1211-1217.
212. Yoshida, T., Chou, T., Matsuda, M., Yasuhara, T., Yazaki, K., Hatano, T. and Okuda, T. (1991). Woodfordin D and oenothein A, trimeric hydrolyzable tannins of macroring structure with antitumor activity, Chem. Pharm. Bull., 39, pp. 1157-1162.
213. Yoshida, T., Jin, Z. and Okuda, T. (1991). Hydrolyzable tannin oligomers from Rosa Davurica, Phytochemistry, 30, pp. 2747-2752.
214. Yoshida, T., Maruyama, T., Nitta, A. and Okuda, T. (1992). Eucalbanins A, B, and C, monomeric and dimeric hydrolyzable tannins from Eucalyptus alba Reinw., Chem. Pharm. Bull., 40, pp. 1750-1754.
215. Yoshida, T., Maruyama, T., Nitta, A. and Okuda, T. (1996). An hydrolysable tannin and accompanying polyphenols from Melaleuca leucadendron, Phytochemistry, 42, pp. 1171-1173.
216. Yui, S., Mikami, M., Mimaki, Y., Sashida, Y. and Yamazaki, M. (2001). Inhibition effect of amaryllidaceae alkaloids, lycorine and lycoricidinol on macrophage TNF-a production, Yakugaku Zasshi, 121, pp. 167-171.
217. Zhou, H., Ding, G., Liu, W., Wang, L., Lu, Y., Cao, H. and Zheng, J. (2004). Lipopolysaccharide could be internalized into human peripheral blood mononuclear cells and elicits TNF-a release, but not via the pathway of Toll-like receptor 4 on the cell surface, Cell. Mol. Immunol., 1, pp. 373-377.
218. Zughaier, S., Zimmer, S., Datta, A., Carlson, R. and Stephens, D. (2005). Differential induction of the Toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins, Infect. Immun., 73, pp. 2940-2950.